BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19670386)

  • 1. Implantable cardioverter defibrillator (ICD) for polymorphic ventricular tachycardia (VT) due to coronary vasospasm.
    Bhat PK; Quan KJ
    J Hosp Med; 2009 Jul; 4(6):E23-5. PubMed ID: 19670386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple episodes of ventricular tachycardia induced by silent coronary vasospasm.
    Sovari AA; Cesario D; Kocheril AG; Brugada R
    J Interv Card Electrophysiol; 2008 Apr; 21(3):223-6. PubMed ID: 18297382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary vasospasm and aborted sudden death treated with an implantable defibrillator and stenting.
    Fiocca L; Di Biasi M; Bruno N; Ciuffreda M; Zumbo F; Mangiameli D; Montenero AS
    Ital Heart J; 2002 Apr; 3(4):270-3. PubMed ID: 12025377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of sudden cardiac death in coronary artery spasm: is implantable cardioverter defibrillator always efficient?
    Letsas KP; Filippatos GS; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2007 Apr; 117(1):141-3. PubMed ID: 17046086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary artery spasm as a cause of ST elevation and inappropriate implantable cardioverter defibrillator intervention.
    Mascioli G; Bontempi L; Racheli M; Cerini M; Curnis A; Cas LD
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):1055-7. PubMed ID: 18163021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate.
    Miyake CY; Webster G; Czosek RJ; Kantoch MJ; Dubin AM; Avasarala K; Atallah J
    Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):579-87. PubMed ID: 23667268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic procedures for coronary vasospasm-induced polymorphic ventricular tachycardia.
    Dresen WF; Wells QS; Maron DJ; McPherson JA
    Ther Adv Cardiovasc Dis; 2012 Jun; 6(3):115-21. PubMed ID: 22547691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The challenges of treating recurrent polymorphic ventricular tachycardia due to coronary vasospasm: Lessons from an interesting case.
    Trehan N; Rehman MU; Kottam A
    J Electrocardiol; 2017; 50(6):972-974. PubMed ID: 28801137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm.
    Sueda S; Kohno H
    Intern Med; 2018 May; 57(10):1361-1369. PubMed ID: 29321418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Importance of ventricular tachycardia storms not terminated by implantable cardioverter defibrillators shocks in patients with CASQ2 associated catecholaminergic polymorphic ventricular tachycardia.
    Marai I; Khoury A; Suleiman M; Gepstein L; Blich M; Lorber A; Boulos M
    Am J Cardiol; 2012 Jul; 110(1):72-6. PubMed ID: 22481011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Implantable cardioverter-defibrillators in patients resuscitated from sudden death and in patients with sustained refractory ventricular tachycardia].
    Adragão P; Parreira L; Neves J; Morgado F; Abecassis M; Almeida M; Martins D; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1996 Mar; 15(3):195-206, 179, 181. PubMed ID: 8634168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
    Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
    Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP; Zareba W; Hall WJ; Schuger C; Corsello A; Leon AR; Andrews ML; McNitt S; Huang DT; Moss AJ;
    J Am Coll Cardiol; 2006 Jan; 47(1):98-107. PubMed ID: 16386671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implantable cardioverter-defibrillator therapy for prevention of sudden cardiac death.
    Akhtar M; Jazayeri MR; Sra JS; Dhala A; Deshpande S; Blanck Z; Axtell K
    Cardiol Clin; 1993 Feb; 11(1):97-108. PubMed ID: 8435827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
    Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Implantable cardioverter-defibrillator(ICD)].
    Kurita T
    Nihon Rinsho; 2002 Jul; 60(7):1353-60. PubMed ID: 12136614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphic ventricular tachycardia induced by coronary vasospasm: a malignant case of variant angina.
    Yuksel UC; Celik T; Iyisoy A; Kursaklioglu H; Amasyali B; Kose S
    Int J Cardiol; 2007 Oct; 121(2):210-2. PubMed ID: 17125857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP; Hall WJ; McNitt S; Wang H; Daubert JP; Zareba W; Ruskin JN; Moss AJ;
    J Am Coll Cardiol; 2005 Nov; 46(9):1712-20. PubMed ID: 16256874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R; McPherson CA; Clancy JF; Caulin-Glaser TL; Rosenfeld LE; Batsford WP
    J Am Coll Cardiol; 2004 Jun; 43(12):2293-9. PubMed ID: 15193696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.